We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B Turnover 22.5%
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.37B
AUM Growth
+$62.8M
Cap. Flow
-$112M
Cap. Flow %
-2.09%
Top 10 Hldgs %
20.35%
Holding
855
New
121
Increased
189
Reduced
310
Closed
120
Avg Time Held
1 year
Top 10 Avg Time Held
0.6 years
Top 20 Avg Time Held
0.6 years

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$45.7M
2
IDXX icon
Idexx Laboratories
IDXX
+$34.3M
3
CAH icon
Cardinal Health
CAH
+$30.2M
4
AMAT icon
Applied Materials
AMAT
+$24.5M
5
ELV icon
Elevance Health
ELV
+$24.1M

Top Sells

Rank Stock Value
1
LYB icon
LyondellBasell Industries
LYB
+$73.1M
2
DOV icon
Dover
DOV
+$41.7M
3
SLB icon
SLB Ltd
SLB
+$40M
4
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$38.2M
5
WYNN icon
Wynn Resorts
WYNN
+$35.4M

Sector Composition

Rank Sector Weight
1 Healthcare 18.73%
2 Financials 15.53%
3 Industrials 13.23%
4 Consumer Discretionary 12.83%
5 Technology 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ESRX
176
DELISTED
Express Scripts Holding Company
ESRX
$2.62M 0.05%
30,894
-377
-1% -$29.5K
2013 Q2
6 quarters
MRSH icon
177
Marsh
MRSH
$89B
$2.57M 0.05%
44,840
+870
+2% +$47.7K
2013 Q4
4 quarters
MO icon
178
Altria Group
MO
$123B
$2.44M 0.05%
49,581
-18,783
-27% -$915K
2013 Q2
6 quarters
FNGN
179
DELISTED
Financial Engines, Inc.
FNGN
$2.4M 0.04%
65,668
+19,492
+42% +$675K
2013 Q2
6 quarters
PSXP
180
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
$2.38M 0.04%
34,590
+1,705
+5% +$111K
2014 Q1
3 quarters
CSCO icon
181
Cisco
CSCO
$433B
$2.33M 0.04%
83,893
+1,862
+2% +$48.1K
2013 Q2
6 quarters
CHSCO icon
182
CHS Inc Class B Preferred Stock
CHSCO
$549M
$2.3M 0.04%
80,605
-645
-0.8% -$18.3K
2013 Q3
5 quarters
ORLY icon
183
O'Reilly Automotive
ORLY
$71.6B
$2.18M 0.04%
169,950
-5,025
-3% -$58.9K
2013 Q2
6 quarters
MDY icon
184
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.6B
$2.17M 0.04%
8,208
+30
+0.4% +$7.68K
2013 Q2
6 quarters
NLY.PRD icon
185
DELISTED
Annaly Capital Management, Inc. 7.50% Series D Cumulative Redeemable Preferred Stock
NLY.PRD
$2.16M 0.04%
86,995
+2,450
+3% +$60.5K
2013 Q2
6 quarters
KMB icon
186
Kimberly-Clark
KMB
$34.6B
$2.15M 0.04%
18,631
-3,722
-17% -$413K
2013 Q2
6 quarters
CEB
187
DELISTED
CEB Inc.
CEB
$2.12M 0.04%
29,272
-1,200
-4% -$82.4K
2013 Q2
6 quarters
KO icon
188
Coca-Cola
KO
$396B
$2.11M 0.04%
49,885
-2,745
-5% -$117K
2013 Q2
6 quarters
BMRN icon
189
BioMarin Pharmaceuticals
BMRN
$10.8B
$2.1M 0.04%
23,222
+1,935
+9% +$161K
2013 Q2
6 quarters
IVV icon
190
iShares Core S&P 500 ETF
IVV
$889B
$2.1M 0.04%
10,147
+2,105
+26% +$426K
2013 Q2
6 quarters
OILT icon
191
DELISTED
OILTANKING PARTNERS L P UIT LTD PARTNERSHIP INT (DE)
OILT
$2.06M 0.04%
44,255
+3,505
+9% +$163K
2014 Q1
3 quarters
MOS icon
192
The Mosaic Company
MOS
$6.02B
$2.05M 0.04%
44,966
-2,497
-5% -$111K
2013 Q2
6 quarters
IWD icon
193
iShares Russell 1000 Value ETF
IWD
$83.7B
$2.05M 0.04%
19,642
+10,638
+118% +$1.08M
2013 Q2
6 quarters
FDX icon
194
FedEx
FDX
$69.9B
$2.04M 0.04%
11,777
-355
-3% -$60K
2013 Q2
6 quarters
AL icon
195
DELISTED
Air Lease Corp
AL
$1.95M 0.04%
56,880
-5,555
-9% -$195K
2014 Q1
3 quarters
SSW.PRD
196
DELISTED
Seaspan Corporation 7.95% Series D Cumulative Redeemable Perpetual Preferred Shares
SSW.PRD
$1.94M 0.04%
75,765
+3,450
+5% +$88.6K
2013 Q4
4 quarters
PRGO icon
197
Perrigo
PRGO
$2.29B
$1.93M 0.04%
11,568
-791
-6% -$124K
2014 Q1
3 quarters
MDVN
198
DELISTED
MEDIVATION, INC.
MDVN
$1.93M 0.04%
38,790
+3,624
+10% +$188K
2014 Q3
1 quarter
BMY icon
199
Bristol-Myers Squibb
BMY
$124B
$1.93M 0.04%
32,710
-878
-3% -$49.5K
2013 Q2
6 quarters
ALXN
200
DELISTED
Alexion Pharmaceuticals
ALXN
$1.92M 0.04%
10,393
+228
+2% +$42.2K
2013 Q2
6 quarters
6 7
8
9 10

Similar funds

CAM
Capstone Asset Management Houston, Texas $3.6B AUM 20.22% 1-Year Est. Return
Virtu KCG Holdings
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
DL
Delta Lloyd Amsterdam, Netherlands $3.56B AUM 18.98% 1-Year Est. Return
Ronald Blue & Co
Ronald Blue & Co Roswell, Georgia $3.1B AUM 12.82% 1-Year Est. Return
TCM
Tetrem Capital Management Winnipeg, Manitoba, Canada $2.29B AUM 16.55% 1-Year Est. Return
HCM
Holland Capital Management Chicago, Illinois $2.28B AUM 23.08% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
AT
Alliance Trust Dundee, Scotland, United Kingdom $1.81B AUM 5.04% 1-Year Est. Return

Geneva Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, Geneva Advisors held 855 positions worth $5.37B, up 1.2% from $5.31B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneva Advisors's Q4 2014 filing shows 121 new, 189 increased, 310 reduced and 120 closed positions. Its largest new stake was Idexx Laboratories: 488,650 shares worth $36.2M. The largest sale was LyondellBasell Industries, an estimated $73.1M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

  • Geneva Advisors's largest Q4 2014 buy was Idexx Laboratories: 488,650 shares worth $36.2M.
  • Geneva Advisors added most to Alibaba in Q4 2014, an estimated $45.7M increase.
  • Geneva Advisors's biggest Q4 2014 reduction was LyondellBasell Industries, cutting an estimated $73.1M.
  • Geneva Advisors fully exited Community Health Systems in Q4 2014, selling an estimated $13M.
  • Geneva Advisors's ten largest holdings make up 20% of its $5.37B portfolio in Q4 2014.
  • Geneva Advisors opened 121 new positions and closed 120 in Q4 2014.
  • Geneva Advisors's portfolio value rose 1.2% quarter-over-quarter to $5.37B.

Based on Geneva Advisors's 13F filing for Q4 2014, filed 2 Feb 2015.